CMS Announces Two Public Meetings To Discuss Clinical Diagnostic Lab Tests
The Centers for Medicare & Medicaid Services (CMS) has announced two public meetings scheduled for later this summer regarding clinical diagnostic laboratory tests.
You may also be interested in...
A panel of industry experts gave the US FDA’s Digital Software Precertification Program the thumbs-up during a MedCon session.
The Food and Drug Administration has designated the recall of a COVID-19 test from SML Distribution LLC as class I, the US agency’s most serious classification.
Sub-standard supplemental oxygen devices that have flooded the market since the COVID-19 pandemic may pose a danger to patients with Chronic Obstructive Pulmonary Disease, a patient advocacy group says.